ENHABIT INC (EHAB) Fundamental Analysis & Valuation

NYSE:EHAB • US29332G1022

Current stock price

13.74 USD
+0.01 (+0.07%)
At close:
13.74 USD
0 (0%)
After Hours:

This EHAB fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. EHAB Profitability Analysis

1.1 Basic Checks

  • In the past year EHAB was profitable.
  • EHAB had a positive operating cash flow in the past year.
  • EHAB had negative earnings in 4 of the past 5 years.
  • In the past 5 years EHAB always reported a positive cash flow from operatings.
EHAB Yearly Net Income VS EBIT VS OCF VS FCFEHAB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M -100M -150M

1.2 Ratios

  • EHAB's Return On Assets of -0.39% is in line compared to the rest of the industry. EHAB outperforms 45.00% of its industry peers.
  • EHAB has a Return On Equity of -0.86%. This is comparable to the rest of the industry: EHAB outperforms 51.00% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 4.84%, EHAB is in line with its industry, outperforming 52.00% of the companies in the same industry.
  • EHAB had an Average Return On Invested Capital over the past 3 years of 3.51%. This is significantly below the industry average of 8.51%.
  • The last Return On Invested Capital (4.84%) for EHAB is above the 3 year average (3.51%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -0.39%
ROE -0.86%
ROIC 4.84%
ROA(3y)-6.25%
ROA(5y)-2.95%
ROE(3y)-14.24%
ROE(5y)-8.07%
ROIC(3y)3.51%
ROIC(5y)4.64%
EHAB Yearly ROA, ROE, ROICEHAB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 -10 -20

1.3 Margins

  • EHAB's Operating Margin of 6.02% is fine compared to the rest of the industry. EHAB outperforms 69.00% of its industry peers.
  • In the last couple of years the Operating Margin of EHAB has declined.
  • With a decent Gross Margin value of 49.04%, EHAB is doing good in the industry, outperforming 76.00% of the companies in the same industry.
  • EHAB's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.02%
PM (TTM) N/A
GM 49.04%
OM growth 3Y-12.91%
OM growth 5Y-8.77%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.25%
GM growth 5Y-0.45%
EHAB Yearly Profit, Operating, Gross MarginsEHAB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. EHAB Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so EHAB is destroying value.
  • The number of shares outstanding for EHAB has been increased compared to 1 year ago.
  • The number of shares outstanding for EHAB has been increased compared to 5 years ago.
  • Compared to 1 year ago, EHAB has an improved debt to assets ratio.
EHAB Yearly Shares OutstandingEHAB Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
EHAB Yearly Total Debt VS Total AssetsEHAB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • EHAB has an Altman-Z score of 1.94. This is not the best score and indicates that EHAB is in the grey zone with still only limited risk for bankruptcy at the moment.
  • EHAB has a Altman-Z score (1.94) which is in line with its industry peers.
  • The Debt to FCF ratio of EHAB is 6.81, which is on the high side as it means it would take EHAB, 6.81 years of fcf income to pay off all of its debts.
  • With a Debt to FCF ratio value of 6.81, EHAB perfoms like the industry average, outperforming 46.00% of the companies in the same industry.
  • A Debt/Equity ratio of 0.80 indicates that EHAB is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.80, EHAB is in line with its industry, outperforming 47.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.8
Debt/FCF 6.81
Altman-Z 1.94
ROIC/WACC0.54
WACC8.91%
EHAB Yearly LT Debt VS Equity VS FCFEHAB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 500M 1B

2.3 Liquidity

  • EHAB has a Current Ratio of 1.63. This is a normal value and indicates that EHAB is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of EHAB (1.63) is better than 65.00% of its industry peers.
  • A Quick Ratio of 1.63 indicates that EHAB should not have too much problems paying its short term obligations.
  • EHAB's Quick ratio of 1.63 is fine compared to the rest of the industry. EHAB outperforms 66.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.63
Quick Ratio 1.63
EHAB Yearly Current Assets VS Current LiabilitesEHAB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. EHAB Growth Analysis

3.1 Past

  • EHAB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 157.14%, which is quite impressive.
  • Looking at the last year, EHAB shows a small growth in Revenue. The Revenue has grown by 2.44% in the last year.
  • Measured over the past years, EHAB shows a decrease in Revenue. The Revenue has been decreasing by -0.34% on average per year.
EPS 1Y (TTM)157.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%250%
Revenue 1Y (TTM)2.44%
Revenue growth 3Y-0.35%
Revenue growth 5Y-0.34%
Sales Q2Q%4.73%

3.2 Future

  • Based on estimates for the next years, EHAB will show a very negative growth in Earnings Per Share. The EPS will decrease by -13.24% on average per year.
  • The Revenue is expected to grow by 5.95% on average over the next years.
EPS Next Y20.26%
EPS Next 2Y11.65%
EPS Next 3Y-7.43%
EPS Next 5Y-13.24%
Revenue Next Year3.52%
Revenue Next 2Y3.86%
Revenue Next 3Y2.76%
Revenue Next 5Y5.95%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EHAB Yearly Revenue VS EstimatesEHAB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M 1B
EHAB Yearly EPS VS EstimatesEHAB Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 0.5 1

More info and screens

Find the best growth stocksShow best growing peers

4

4. EHAB Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 25.44 indicates a quite expensive valuation of EHAB.
  • Compared to the rest of the industry, the Price/Earnings ratio of EHAB indicates a somewhat cheap valuation: EHAB is cheaper than 62.00% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.47, EHAB is valued at the same level.
  • EHAB is valuated rather expensively with a Price/Forward Earnings ratio of 21.16.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of EHAB is on the same level as its industry peers.
  • EHAB's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.62.
Industry RankSector Rank
PE 25.44
Fwd PE 21.16
EHAB Price Earnings VS Forward Price EarningsEHAB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EHAB indicates a somewhat cheap valuation: EHAB is cheaper than 63.00% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of EHAB indicates a rather cheap valuation: EHAB is cheaper than 81.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 10.59
EV/EBITDA 12.76
EHAB Per share dataEHAB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

  • EHAB's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • EHAB's earnings are expected to decrease with -7.43% in the coming years. This may justify a cheaper valuation.
PEG (NY)1.26
PEG (5Y)N/A
EPS Next 2Y11.65%
EPS Next 3Y-7.43%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. EHAB Dividend Analysis

5.1 Amount

  • EHAB does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

EHAB Fundamentals: All Metrics, Ratios and Statistics

ENHABIT INC

NYSE:EHAB (4/23/2026, 4:15:00 PM)

After market: 13.74 0 (0%)

13.74

+0.01 (+0.07%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)03-04
Earnings (Next)05-13
Inst Owners97.8%
Inst Owner ChangeN/A
Ins Owners2.51%
Ins Owner Change7.54%
Market Cap696.89M
Revenue(TTM)1.06B
Net Income(TTM)-4.60M
Analysts50.91
Price Target14.11 (2.69%)
Short Float %2.76%
Short Ratio0.81
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)17.89%
Min EPS beat(2)-3.12%
Max EPS beat(2)38.89%
EPS beat(4)3
Avg EPS beat(4)28.08%
Min EPS beat(4)-3.12%
Max EPS beat(4)53.19%
EPS beat(8)5
Avg EPS beat(8)19.11%
EPS beat(12)6
Avg EPS beat(12)9.32%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.65%
Min Revenue beat(2)-3.27%
Max Revenue beat(2)-2.02%
Revenue beat(4)0
Avg Revenue beat(4)-2.62%
Min Revenue beat(4)-4.23%
Max Revenue beat(4)-0.95%
Revenue beat(8)0
Avg Revenue beat(8)-3.27%
Revenue beat(12)0
Avg Revenue beat(12)-3.56%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)15.6%
PT rev (3m)30.5%
EPS NQ rev (1m)-4.69%
EPS NQ rev (3m)24.49%
EPS NY rev (1m)5.23%
EPS NY rev (3m)13.69%
Revenue NQ rev (1m)-0.62%
Revenue NQ rev (3m)-0.33%
Revenue NY rev (1m)-0.8%
Revenue NY rev (3m)-0.62%
Valuation
Industry RankSector Rank
PE 25.44
Fwd PE 21.16
P/S 0.66
P/FCF 10.59
P/OCF 9.86
P/B 1.31
P/tB N/A
EV/EBITDA 12.76
EPS(TTM)0.54
EY3.93%
EPS(NY)0.65
Fwd EY4.73%
FCF(TTM)1.3
FCFY9.44%
OCF(TTM)1.39
OCFY10.15%
SpS20.9
BVpS10.53
TBVpS-7.09
PEG (NY)1.26
PEG (5Y)N/A
Graham Number11.3102 (-17.68%)
Profitability
Industry RankSector Rank
ROA -0.39%
ROE -0.86%
ROCE 6.13%
ROIC 4.84%
ROICexc 5.05%
ROICexgc 48.74%
OM 6.02%
PM (TTM) N/A
GM 49.04%
FCFM 6.21%
ROA(3y)-6.25%
ROA(5y)-2.95%
ROE(3y)-14.24%
ROE(5y)-8.07%
ROIC(3y)3.51%
ROIC(5y)4.64%
ROICexc(3y)3.62%
ROICexc(5y)4.73%
ROICexgc(3y)35.01%
ROICexgc(5y)50.85%
ROCE(3y)4.44%
ROCE(5y)5.87%
ROICexgc growth 3Y-7.89%
ROICexgc growth 5Y-10.93%
ROICexc growth 3Y-3.5%
ROICexc growth 5Y-1.99%
OM growth 3Y-12.91%
OM growth 5Y-8.77%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.25%
GM growth 5Y-0.45%
F-Score7
Asset Turnover0.91
Health
Industry RankSector Rank
Debt/Equity 0.8
Debt/FCF 6.81
Debt/EBITDA 4.94
Cap/Depr 21.78%
Cap/Sales 0.46%
Interest Coverage 1.97
Cash Conversion 81.92%
Profit Quality N/A
Current Ratio 1.63
Quick Ratio 1.63
Altman-Z 1.94
F-Score7
WACC8.91%
ROIC/WACC0.54
Cap/Depr(3y)15.06%
Cap/Depr(5y)38.37%
Cap/Sales(3y)0.39%
Cap/Sales(5y)1.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)157.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%250%
EPS Next Y20.26%
EPS Next 2Y11.65%
EPS Next 3Y-7.43%
EPS Next 5Y-13.24%
Revenue 1Y (TTM)2.44%
Revenue growth 3Y-0.35%
Revenue growth 5Y-0.34%
Sales Q2Q%4.73%
Revenue Next Year3.52%
Revenue Next 2Y3.86%
Revenue Next 3Y2.76%
Revenue Next 5Y5.95%
EBIT growth 1Y36.03%
EBIT growth 3Y-13.21%
EBIT growth 5Y-9.08%
EBIT Next Year40.02%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y38.82%
FCF growth 3Y21.48%
FCF growth 5Y25.31%
OCF growth 1Y38.09%
OCF growth 3Y-4.08%
OCF growth 5Y23.21%

ENHABIT INC / EHAB Fundamental Analysis FAQ

What is the fundamental rating for EHAB stock?

ChartMill assigns a fundamental rating of 4 / 10 to EHAB.


What is the valuation status for EHAB stock?

ChartMill assigns a valuation rating of 4 / 10 to ENHABIT INC (EHAB). This can be considered as Fairly Valued.


What is the profitability of EHAB stock?

ENHABIT INC (EHAB) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for EHAB stock?

The Price/Earnings (PE) ratio for ENHABIT INC (EHAB) is 25.44 and the Price/Book (PB) ratio is 1.31.


What is the financial health of ENHABIT INC (EHAB) stock?

The financial health rating of ENHABIT INC (EHAB) is 4 / 10.